Legal & General Group Plc - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 98 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 1.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$293,218
-30.9%
125,844
+32.7%
0.00%
Q1 2024$424,032
+60.8%
94,862
+15.5%
0.00%
Q4 2023$263,721
+2.3%
82,156
+1.0%
0.00%
Q3 2023$257,749
-32.8%
81,309
+5.3%
0.00%
Q2 2023$383,715
+0.6%
77,2060.0%0.00%
Q1 2023$381,397
-18.6%
77,206
+3.6%
0.00%
Q4 2022$468,757
-40.7%
74,524
+1.9%
0.00%
Q3 2022$790,000
-8.0%
73,142
-3.0%
0.00%
Q2 2022$859,000
+51.8%
75,372
+21.3%
0.00%
Q1 2022$566,000
-38.9%
62,141
+0.2%
0.00%
Q4 2021$926,000
-41.9%
62,0290.0%0.00%
-100.0%
Q3 2021$1,593,000
+66.1%
62,029
+68.7%
0.00%
Q2 2021$959,000
-27.1%
36,768
-1.3%
0.00%
Q1 2021$1,316,000
+91.6%
37,266
+36.9%
0.00%
Q4 2020$687,000
-33.2%
27,227
-0.2%
0.00%
Q3 2020$1,029,000
-16.5%
27,279
-5.2%
0.00%
-100.0%
Q2 2020$1,232,000
+148.4%
28,762
+12.9%
0.00%
Q1 2020$496,000
-29.7%
25,473
-6.3%
0.00%
Q4 2019$706,000
+33.2%
27,176
+39.7%
0.00%
Q3 2019$530,000
+1.5%
19,4470.0%0.00%
Q2 2019$522,000
-82.3%
19,447
-80.9%
0.00%
-100.0%
Q1 2019$2,947,000
+3211.2%
102,030
+2983.4%
0.00%
Q4 2018$89,0003,3090.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$4,189,7204.58%
SUPERSTRING CAPITAL MANAGEMENT LP 689,912$1,607,4952.03%
Lynx1 Capital Management LP 2,228,295$5,191,9271.87%
Wildcat Capital Management, LLC 2,920,787$6,805,4341.66%
TPG GP A, LLC 18,716,306$43,608,9931.00%
Boxer Capital, LLC 3,850,000$8,970,5000.47%
Vestal Point Capital, LP 2,200,000$5,126,0000.38%
DAFNA Capital Management LLC 605,100$1,409,8830.34%
Frazier Life Sciences Management, L.P. 2,867,750$6,681,8580.31%
Coastal Bridge Advisors, LLC 406,847$947,9540.24%
View complete list of ALLOGENE THERAPEUTICS INC shareholders